Presenter: Rochelle Sharpe Lohrasbe, PhD, RCC 
Presenter Bio: Rochelle Sharpe Lohrasbe, PhD, RCC, is a Registered Clinical Counsellor who holds an MA in Learning and Development and a PhD in Child and Youth Care. Rochelle began her career in forensic psychiatric nursing and she has accumulated more than 30 years of clinical experience in the areas of post-traumatic stress and developmental wounding. In her private clinical practice in British Columbia, Canada, Rochelle sees “children of all ages” who have endured abuse, neglect, and other traumatic/adverse experiences. She is a Sensorimotor Psychotherapy local, regional, and international facilitator and a curriculum/instructional design consultant, an EMDRIA-approved consultant and holds certifications in Clinical Hypnosis, Neuroptimal Neurofeedback and Havening Techniques. Rochelle presents regularly at ISSTD conferences and regional workshops internationally and provides educational workshops for psychotherapists on Trauma and Dissociation. She recently published on the integration of EMDR and SP, and co-authored “Somatic Resources: Sensorimotor Psychotherapy Approach to Stabilising Arousal in Child and Family Treatment” (2017), published in the Australian and New Zealand Journal of Family Therapy.

Presenter: Kate Browning, Dip. Midwifery, BScN, MA, PhD (cand), RN
Presenter Bio: Kate Browning is a psychotherapist and doctoral candidate in clinical psychology, a somatic psychotherapist specialized in trauma and attachment, and a Registered Nurse specialized in mental health and substance use. She is a former licensed and registered midwife, and is extensively trained in subtle energy and consciousness-based healing practices. Kate has worked in a variety of health care and educational settings for over 25 years as a clinician, clinical supervisor, lecturer, consultant, educator, administrator, She has trained in ketamine-assisted psychotherapy at the Orenda Institute and with the Center for Transformational Psychotherapy, and is training in MDMA-assisted psychotherapy for PTSD with the Multidisciplinary Association for Psychedelic Studies, with whom she will be conducting research in 2021-22. Kate is a clinical advisory council member and research clinician for Numinus Wellness Inc., a company dedicated to research and delivery of accessible psychedelic therapies to improve the mental health of all Canadians. She is a founding and board member of the Canadian Psychedelic Association and of the Ketamine-Assisted Psychotherapy Association of British Columbia. Kate has presented at the Family Caregivers Association of Alberta, the Spirit Plant Medicine Conference, and the Psychedelic Psychotherapy Forum.